Posted on 3/11/20
DFP Healthcare Acquisitions Corp. Prices $200M IPO
NEW YORK--(BUSINESS WIRE)--DFP Healthcare Acquisitions Corp. announced today the pricing of its initial public offering of 20,000,000 units at a price of $10.00 per unit. The . . .
Posted on 3/10/20
Angelini Pharma Acquires ThermaCare From GSK
Angelini Pharma announces today it has acquired the ThermaCare global business rights, excluding North America, from GSK.
Posted on 3/10/20
JLL Partners and Bart Doedens Join to Launch Renovo Health
NEW YORK--(BUSINESS WIRE)--JLL Partners today announced it has entered into a partnership with Bart Doedens, a highly regarded and accomplished leader in the biomedical industry, to form . . .
Posted on 3/10/20
Why Pfizer Stock Is Plunging Today
What happenedBig pharma titan Pfizer Inc. (NYSE:PFE) is having a painful morning. The drugmaker's shares dipped by as much as 5.4% in early morning trading Monday . . .
Posted on 3/10/20
Coronavirus Concerns Have Big Pharma Working From Home
Over the past few days, health officials in Cambridge, Massachusetts, reported on a cluster of 26 cases of COVID-19 that were traced to a Biogen (NASDAQ:BIIB) . . .
Posted on 3/10/20
JFK Johnson Stroke-HEART Trials Recognized As Top Research in Rehabilitation Medicine
A national medical society on Sunday recognized a study from the JFK Johnson Stroke-HEART™ Trials as the best research published last year in the field's most . . .
Posted on 3/10/20
IronHealth Enters into Preferred Partnership with PeriGen
IronHealth, the healthcare professional liability and stop loss unit of Ironshore, has entered into a preferred partnership with PeriGen, a perinatal software solutions provider, offering insureds . . .
Posted on 3/9/20
Genentech, Pfizer and Merck Identified as the Top Three Companies Driving Therapeutic Innovation in Breast Cancer
In a recent study conducted by KMK Consulting, Inc., covering Innovation & Customer Value in the Breast Cancer market, Genentech (a member of the Roche Group) . . .
Posted on 3/9/20
Bayer Partners with MassBio to Launch Center for Regulatory Excellence to Support Startup Community
WHIPPANY, N.J. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Bayer and MassBio today announced the Center for Regulatory Excellence, a first-of-its-kind forum for startups and academia to interact with and learn . . .
Posted on 3/9/20
Matinas BioPharma Reports Fourth Quarter and Full Year 2019 Financial Results and Operational Highlights
BEDMINSTER, N.J., March 09, 2020 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), a clinical-stage biopharmaceutical company, today reported financial results for the fourth . . .
Posted on 3/9/20
Trump Signs $8.3 Billion Coronavirus Funding Measure
President Donald Trump has signed an appropriations bill that allocates $8.3 billion to various arms of the federal government to fight the spread of SARS-CoV-2, the . . .
Posted on 3/9/20
Johnson & Johnson: A Steadily Growing Dividend Compounder, Buy Low On Coronavirus Fears
SummaryJohnson & Johnson is a multinational medical devices and pharmaceutical company.The company has a track record of healthy cash flows, shareholder-friendly dividend policy, sufficient liquidity and . . .
Posted on 3/9/20
Pfizer At Attractive Valuation
SummaryYOY Pfizer is down on revenues and cash flow, stock price reflecting such.Guidance lowered for 2020, but operations becoming streamlined.Coronavirus fears affecting overall market and will . . .
Posted on 3/8/20
BrainStorm Cell Therapeutics Raises $10.0M in Common Stock Sale at $8.00 Per Share
NEW YORK, March 06, 2020 (GLOBE NEWSWIRE) -- BrainStorm Cell Therapeutics Inc., (NASDAQ: BCLI), a leading developer of cell technologies for neurodegenerative diseases, today announced that . . .
Posted on 3/8/20
TG Therapeutics Provides Business Update
NEW YORK, March 03, 2020 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced its financial results for the fourth quarter and year ended December . . .
Posted on 3/8/20
Daxor Corp. Announces Pricing of $2.0 Million Registered Direct Offering
NEW YORK, March 03, 2020 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE American: DXR), an investment company with innovative medical instrumentation and biotechnology operations focused on blood . . .
Posted on 3/8/20
Mount Sinai and Harbour BioMed Collaborate
NEW YORK & CAMBRIDGE, Mass. & ROTTERDAM, Netherlands & SUZHOU, China--(BUSINESS WIRE)--Mount Sinai Health System and Harbour BioMed (HBM) have entered into a multi-year, multifaceted collaboration . . .
Posted on 3/8/20
Bioasis Announces Proposed Redemption of 15% Unsecured Debentures
GUILFORD, Conn.--(BUSINESS WIRE)--BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF; TSX.V:BTI), a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB3 ™ platform technology for the delivery of therapeutics across the . . .
Posted on 3/6/20
Why Regeneron Shares Rose 31.6% in February
What happenedShares of Regeneron Pharmaceuticals (NASDAQ:REGN) rose 31.6% in February, according to data provided by S&P Global Market Intelligence, after the company expanded its work with . . .
Posted on 3/5/20
Cantel Medical Reports Financial Results for its Second Quarter Fiscal Year 2020
Cantel Medical Corp. (NYSE: CMD) today announced financial results for its second quarter ended January 31, 2020.Second quarter 2020 net sales were $288.5M, up 28.5% compared . . .
Posted on 3/5/20
Why Pfizer Stock Tanked in February
What happenedShares of the multinational pharmaceutical giant Pfizer (NYSE:PFE) slid by a noteworthy 10.3% over the course of February, according to data from S&P Global Market . . .
Posted on 3/4/20
National Kidney Foundation and CVS Kidney Care have Joined Forces to Promote Kidney Health
The National Kidney Foundation (NKF) and CVS Kidney Care, a CVS Health company, are partnering on a national campaign to raise awareness about kidney disease which . . .
Posted on 3/4/20
How Antares Pharma Beat Expectations in Q4
Antares Pharma (NASDAQ:ATRS) finished 2019 on a positive note, with the stock jumping nearly 73% last year. But it's been pretty much all downhill for shares . . .
Posted on 3/4/20
Teladoc Health's Stock Spikes 30% Amid Coronavirus Fear, but Be Wary of Chasing It
Shares of Teladoc Health (NYSE:TDOC) have been on a tear, up more than 400% over the past three years and even bucking the steep coronavirus-fueled market . . .
Posted on 3/4/20
Why Teladoc Health Stock Popped 23% in February While the Market Dropped
What happenedTeladoc Health (NYSE:TDOC) stock jumped 22.9% in February, according to data from S&P Global Market Intelligence. That's a particularly strong gain when you consider that . . .
New York
